VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $2,733,000 | +9.1% | 19,100 | 0.0% | 3.74% | +89.7% |
| Q3 2014 | $2,506,000 | +158.1% | 19,100 | +148.1% | 1.97% | +289.9% |
| Q2 2014 | $971,000 | -52.2% | 7,700 | -50.0% | 0.50% | -53.4% |
| Q1 2014 | $2,030,000 | -62.7% | 15,400 | -66.7% | 1.08% | -63.6% |
| Q4 2013 | $5,436,000 | -57.8% | 46,300 | -62.5% | 2.98% | -58.0% |
| Q3 2013 | $12,895,000 | +21.2% | 123,600 | 0.0% | 7.10% | +25.8% |
| Q2 2013 | $10,639,000 | – | 123,600 | – | 5.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |